Shao-lee Lin - Net Worth and Insider Trading
Shao-lee Lin Net Worth
The estimated net worth of Shao-lee Lin is at least $11 Million dollars as of 2024-12-27. Shao-lee Lin is the CEO of Acelyrin Inc and owns about 3,452,329 shares of Acelyrin Inc (SLRN) stock worth over $11 Million. Details can be seen in Shao-lee Lin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shao-lee Lin has not made any transactions after 2024-04-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shao-lee Lin
Shao-lee Lin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shao-lee Lin owns 6 companies in total, including Principia Biopharma Inc (PRNB) , Horizon Therapeutics PLC (HZNP) , and Surrozen Inc (SRZN) among others .
Click here to see the complete history of Shao-lee Lin’s form 4 insider trades.
Insider Ownership Summary of Shao-lee Lin
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PRNB | Principia Biopharma Inc | 2020-09-28 | director |
HZNP | Horizon Therapeutics PLC | 2018-01-04 | EVP & Head of R&D and CSO |
SRZN | Surrozen Inc | 2021-08-11 | director |
2021-08-11 | director | ||
2022-09-14 | director | ||
2024-04-01 | director & Chief Executive Officer |
Shao-lee Lin Latest Holdings Summary
Shao-lee Lin currently owns a total of 1 stock. Shao-lee Lin owns 3,452,329 shares of Acelyrin Inc (SLRN) as of April 1, 2024, with a value of $11 Million.
Latest Holdings of Shao-lee Lin
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SLRN | Acelyrin Inc | 2024-04-01 | 3,452,329 | 3.32 | 11,461,732 |
Holding Weightings of Shao-lee Lin
Shao-lee Lin Form 4 Trading Tracker
According to the SEC Form 4 filings, Shao-lee Lin has made a total of 3 transactions in Acelyrin Inc (SLRN) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Acelyrin Inc is the sale of 9,961 shares on April 1, 2024, which brought Shao-lee Lin around $66,041.
Insider Trading History of Shao-lee Lin
- 1
Shao-lee Lin Trading Performance
Shao-lee Lin Ownership Network
Shao-lee Lin Owned Company Details
What does Principia Biopharma Inc do?
Who are the key executives at Principia Biopharma Inc?
Shao-lee Lin is the director of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .
Principia Biopharma Inc (PRNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Principia Biopharma Inc Insider Transactions
Shao-lee Lin Mailing Address
Above is the net worth, insider trading, and ownership report for Shao-lee Lin. You might contact Shao-lee Lin via mailing address: C/o Acelyrin, Inc., 4149 Liberty Canyon Rd., Agoura Hills Ca 91301.